Novo Nordisk’s Wegovy and copyright, equally powered by semaglutide, have revolutionized obesity treatment through unparalleled weight loss success.Problems with diabetic retinopathy: Diabetic retinopathy is an eye situation leading to harm to the blood vessels in the attention that could arise in individuals with diabetes.By 2022 the popularity